Pharmaceutical lobbying under postcommunism: Universal or country-specific methods of securing state drug reimbursement in Poland?

Piotr Ozieranski, L. King, M. McKee

Research output: Contribution to journalArticlepeer-review

21 Citations (Scopus)

Abstract

This paper aims to fill in the gap in research on the effect of pharmaceutical lobbying on drug reimbursement policy, particularly in Poland, a post-communist country. To this end, we conducted in-depth, semi-structured, anonymous, elite interviews in Poland, supplemented by a review of legislation, policy documents, official reports and press articles, as well as observations. Overall, 109 representatives of stakeholders involved in reimbursement policy were interviewed. We identified two key lobbying methods: informal persuasion and third-party endorsements. These methods are coupled with two supplementary ones: lobbying through parliament and ministries, as well as diplomatic pressure. Pharmaceutical lobbying methods in Poland clearly resemble those used in other European countries. What is notable about the Polish case is extensive reliance on informal lobbying and diplomatic pressure.
Original languageEnglish
Pages (from-to)175-195
Number of pages21
JournalHealth Economics, Policy and Law
Volume7
Issue number2
DOIs
Publication statusPublished - 1 Apr 2012

Fingerprint Dive into the research topics of 'Pharmaceutical lobbying under postcommunism: Universal or country-specific methods of securing state drug reimbursement in Poland?'. Together they form a unique fingerprint.

Cite this